Drug Development in Pemphigoid Diseases

Acta Dermato-Venereologica - Sweden
doi 10.2340/00015555-3400
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Acta Dermato-Venereologica

Related search

Drug Development to Protozoan Diseases

Open Medicinal Chemistry Journal
Drug DiscoveryMolecular MedicinePharmacologyPharmaceutical Science
2011English

Mucous Membrane Pemphigoid and Oral Blistering Diseases

Clinical and Experimental Dermatology
Dermatology
2019English

Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases

Frontiers in Immunology
AllergyImmunology
2017English

Development of an ELISA for Sensitive and Specific Detection of IgA Autoantibodies Against BP180 in Pemphigoid Diseases

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

The Associations Between Bullous Pemphigoid and Drug Use

JAMA Dermatology
DermatologyMedicine
2013English

Role of Immune Cells in the Ocular Manifestations of Pemphigoid Diseases

Therapeutic Advances in Ophthalmology
2019English

Tropical Protozoan Diseases: Natural Product Drug Discovery and Development

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2013English

Rare Diseases, Drug Development, and AIDS: The Impact of the Orphan Drug Act

Milbank Quarterly
Health PolicyPublic HealthOccupational HealthEnvironmental
1995English

351 Clinical Characterization of Bullous Pemphigoid and Mucous Membrane Pemphigoid Diseases: Analysis of a National and Local Dataset

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy